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August 28, 2012:869–74paper should be that there is no increase in lumen dimensions as
seen by IVUS.
In addition to this, the IVUS data reported in the table partially
differ from those reported in the text and includes the measure-
ment of intimal hyperplasia in the coronary segment distal to the
recanalized CTO, where no stent was implanted and no intimal
hyperplasia could therefore be measured (8).
Finally, the authors underestimated the role of the drug-eluting
tent (DES)–dependent endothelial dysfunction, which is nor-
ally present in the coronary segment distal to a first-generation
ES, caused by the downstream elution of the antiproliferative
rug and that has disappeared with the introduction of second-
eneration DES (5). As the vasomotion substudy included only
atients with first-generation DESs, the persistence or the wors-
ning of the endothelial dysfunction at follow-up distal to the stent
reviously implanted could be first-generation DES-related and
ot deriving from a long-acting endothelial dysfunction of the
oronary segment distal the CTO after recanalization.
Based on these concerns, most of the findings of the present
tudy should be taken as hypothesis generating and would need
urther investigation in a well-designed and powered study.
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Reply
We thank Dr. Brugaletta and colleagues for their valuable com-
ments on our paper (1).
First, as they point out, 3-dimensional quantitative coronary
angiography (3D-QCA) might overcome several limitations of
2-dimensional (2D-QCA), as previously shown also in our previ-
ous experience (2). We concur that it is unusual to select as the
primary measurement the reference vessel diameter (RVD) instead
of minimal lumen diameter in this kind of investigation. We made
this decision because it was unknown at the beginning of the study
whether changes in the vessel caliper would be ascribed to coronary
vasomotion or to a remodeling phenomenon. Moreover, we
disagree that measuring 3 single QCA points might limit the study
results. Indeed, with this method, we were able to provide coronary
measurements at a certain point and reproduce them at follow-up,
further assessing the relationship between vessel diameter mea-
surement and its percentage of variation.
Second, differently from the standards (3), we decided to
erform intravascular ultrasound (IVUS) analysis every 5 mm,
onsidering the very long coronary segments assessed. Thus, we
ere able to limit the bias related to data clustering. Notably, with
uch analysis, it was easier to reproduce measurements at follow-
p. We probably did not observe any changes in IVUS measure-
ents because of the small sample size of the IVUS substudy,
hich was not sufficiently powered to show any significant differ-
nce. In this regard, we would like to emphasize that the primary
ndpoint of the main analysis was the RVD at angiographic
ollow-up as assessed by 3D-QCA, and for this evaluation, an
ppropriate pre-specified sample size was used.
Third, we truly concur with Dr. Brugaletta and colleagues
egarding the possibility that because the vasomotion substudy
ncluded only patients receiving first-generation drug-eluting
tents (DESs), the persistence or worsening of the endothelial
ysfunction at follow-up distal to the implanted stent could be
rst-generation DES related and not caused by a long-acting
ndothelial dysfunction of the coronary segment distal to the CTO
fter recanalization. This is a limitation that was discussed in the
ext.
Fourth, we apologize to the editor and readers for some typing
nd spelling errors in the Results section, which did not substan-
ially affect the study conclusions.
Finally, we believe that our study clearly shows that recanaliza-
ion of CTO is followed by a reversible hibernation of the vascular
all at distal coronary segments, which determine an increase in
essel diameter on long-term follow-up due to an increase in shear
tress. We hope that using our findings as hypothesis generating,
uture sufficiently powered investigations will provide a better
xplanation of this phenomenon.
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QRS Morphology
Is Equally Important!
We read with great interest the TARGET (Targeted Left Ven-
tricular Lead Placement to Guide Cardiac Resynchronization
Therapy) study by Khan et al. (1), a randomized controlled trial
with targeted left ventricular (LV) lead placement to guide cardiac
resynchronization therapy. The results of the study are promising
and do emphasize the importance of the location of the LV lead in
relation to the latest segment of contraction. However, many
conventional variables have not been identified in the study, and
more data are needed to support the conclusions of the study.
Morphology of the QRS complex (left bundle branch block vs.
right bundle branch block vs. nonspecific intraventricular conduc-
tion delay) has not been reported in the study. Many previous
studies have consistently shown that QRS morphology is one of
the most important predictors of response (2). The distribution of
left bundle branch block between both groups should be identified
as it can potentially influence the results.
It will be interesting to see if there is a correlation between the
QRS morphology and axis with the latest segment of contraction
in this study. It is postulated that QRS morphology and frontal
axis can predict the latest segment of activation; whether it would
predict the latest segment of mechanical contraction is unknown
(3). Khan et al. (1) do have the unique opportunity to evaluate this
concept in their study population. Nearly one-half (47%) of the
patients in the control group ended up having a concordant LV
lead location in relation to the segment of latest contraction. It
would be very helpful to identify the surface electrocardiogram
characteristics (QRS morphology and axis) of this subgroup and
compare them with those of patients in whom the LV lead was not
concordant. If it is possible to predict the area of latest contraction,with reasonable accuracy, using surface electrocardiogram mor-
phology, it would make the concept of “targeting LV lead” much
easier and widely acceptable, without the use of the more sophis-
ticated radial strain measurement.
Total scar burden, an important variable in predicting outcomes
in cardiac resynchronization therapy (4) has not been reported in
his study. Patients with higher scar burden are intuitively more
ikely to have a scar at the LV lead site and are less likely to have
concordant LV lead (more remote or adjacent location), thereby
ignificantly influencing the results. The mean total scar burden in
oth groups should be reported in the study to support the
onclusions.
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We are grateful for the comments and interest shown by Drs.
Reddy and Lakkireddy with respect to our recent publication of
the TARGET (Targeted Left Ventricular Lead Placement to
Guide Cardiac Resynchronization Therapy) study (1) regarding
targeted left ventricular (LV) lead placement to guide cardiac
resynchronization therapy (CRT). We do not believe that there are
robust data to justify the title of their letter and have addressed the
specific points below.
First, the morphology of the QRS complex is not, as of yet, part
of the guidelines for patients who should be recommended CRT
even though, as pointed out by the authors, a number of studies
have shown that it is an important determinant of response (2).
The centers recruiting for the study routinely implant patients with
only baseline left bundle branch block (LBBB) morphology.
Reflecting this, there were only 2 patients who had non-LBBB
morphology, distributed equally in each group. In both patients,
the electrocardiogram showed right bundle branch block morphol-
ogy, the latest segment of activation was in the inferoseptum, the
final lead position was remote, and both patients were CRT
